Role of RPE cells in Age Related Macular Degeneration
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2001 - March 31, 2002
Grant ID
M2001008
Summary
Normal RPE cells form a single cell layer that supports the function of the retina. It is believed that the cells in this “monolayer” do not divide. Instead, they strongly adhere to each other and form cell-cell communications that support vision. Unfortunately, these cell adhesions and communication are lost because of inflammation in the wet form of AMD. When inflammation occurs, RPE cells secrete many growth factors and respond to them with their receptors. One of these factors is hepatocyte growth factor (HGF), which stimulates the division and migration of RPE and blood vessel endothelial cells. HGF also stimulates the production of other growth factors that promote the formation of new blood vessels and allow the invasion of the blood vessel cells into the neighboring matrix, which is an early event of neovascularization. Dr. Liou will study RPE cells treated with HGF to understand the mechanism of cell growth and migration induced by HGF. He will also examine surgically excised CNV membranes from patients with AMD to determine whether an HGF receptor is expressed in these membranes. He will study the role of HGF in CNV formation in mice by testing a recently discovered HGF-related protein, which has been shown to reduce new blood vessel formation in a number of tissues.
Grants
Related Grants
Macular Degeneration Research
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Neetu Kushwah, PhD
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Neetu Kushwah, PhD
Macular Degeneration Research
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Krishna Singh, PhD
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Krishna Singh, PhD
Macular Degeneration Research
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shintaro Shirahama, MD, PhD
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Shintaro Shirahama, MD, PhD